Biobank for Inflammatory Chronic Diseases and Osteoporosis
Recruiting now
Conditions studied: Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, Osteoporosis
In brief
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
Key facts
- Study ID
- NCT05039216
- Run by
- University Hospital, Toulouse
- People needed
- 2000
- Starts
- 2021-09-13
- Expected to finish
- 2031-09-01
- Last updated by the study team
- 2026-03-19
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
- With National Health Assurance
- Able to consent to the study
You may not qualify if…
- Pregnancy or breastfeeding
- Not able to give a consent
- Severe anemia (Hb<10g/L)
Where it is running
- Purpan University Hospital — Toulouse, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.